Search Result "desialylated LDL"
Electronegative LDL: An Active Player in Atherogenesis or a By- Product of Atherosclerosis?
Journal: Current Medicinal Chemistry
Volume: 26 Issue: 9 Year: 2019 Page: 1665-1679
Author(s): Andrea Rivas-Urbina,Anna Rull,Jordi Ordóñez-Llanos,José Luis Sánchez-Quesada
Multiple-modified Low-Density Lipoprotein as Atherogenic Factor of Patients' Blood: Development of Therapeutic Approaches to Reduce Blood Atherogenicity
Journal: Current Pharmaceutical Design
Volume: 23 Issue: 6 Year: 2017 Page: 932-936
Author(s): Nikita G. Nikifirov,Emile R. Zakiev,Natalia V. Elizova,Vasily N. Sukhorukov,Alexander N. Orekhov
Sialidases: Therapeutic and Antiatherogenic Potential
Journal: Current Pharmaceutical Design
Volume: 23 Issue: 31 Year: 2017 Page: 4696-4701
Author(s): Vasily Nikolaevich Sukhorukov,Vasily Petrovich Karagodin,Emile Rustemovich Zakiev,Andrey Vyacheslavovich Grechko,Alexandr Nikolaevich Orekhov
Modified LDL Immune Complexes and Cardiovascular Disease
Journal: Current Medicinal Chemistry
Volume: 26 Issue: 9 Year: 2019 Page: 1680-1692
Author(s): Maria F. Lopes-Virella,Gabriel Virella
Prospects for the Use of Sialidase Inhibitors in Anti-atherosclerotic Therapy
Journal: Current Medicinal Chemistry
Volume: 28 Issue: 12 Year: 2021 Page: 2438-2450
Author(s): Igor A. Sobenin,Alexander M. Markin,Victor Y. Glanz,Yuliya V. Markina,Wei-Kai Wu,Veronika A. Myasoedova,Alexander N. Orekhov
Blood Atherogenicity as a Target for Anti-atherosclerotic Therapy
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 3 Year: 2013 Page: 5954-5962
Author(s): Igor A. Sobenin, Dimitry A. Chistiakov, Yuri V. Bobryshev, Anton Y. Postnov, Alexander N. Orekhov
Modified and Dysfunctional Lipoproteins in Atherosclerosis: Effectors or Biomarkers?
Journal: Current Medicinal Chemistry
Volume: 26 Issue: 9 Year: 2019 Page: 1512-1524
Author(s): Alexander N. Orekhov,Igor A. Sobenin
Non-oxidative vs Oxidative Forms of Modified Low-density Lipoprotein:What is More Important in Atherogenesis?
Journal: Current Medicinal Chemistry
Volume: 31 Issue: 17 Year: 2024 Page: 2309-2313
Author(s):
Is Oxidized Low-Density Lipoprotein a Principal Actor in Atherogenesis?
Journal: Current Medicinal Chemistry
Volume: 31 Issue: 42 Year: 2024 Page: 6909-6910
Author(s):
Trans-sialidase Associated with Atherosclerosis: Defining the Identity of a Key Enzyme Involved in the Pathology
Journal: Current Drug Targets
Volume: 20 Issue: 9 Year: 2019 Page: 938-941
Author(s): Victor Yu. Glanz,Veronika A. Myasoedova,Andrey V. Grechko,Alexander N. Orekhov